| Rahn Antonio Ravenell, DPM | |
|
171 Ashley Ave, Charleston, SC 29425-1810 | |
| (843) 792-1414 | |
| Not Available |
| Full Name | Rahn Antonio Ravenell |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 17 Years |
| Location | 171 Ashley Ave, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639492473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | POD001109 (Georgia) | Secondary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 603 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Associates Of The Medical University Of South Carol | 6305758574 | 1297 |
News Archive
People with anorexia nervosa struggle with questions about their real, or "authentic," self - whether their illness is separate from or integral to them - and this conflict has implications for compulsory treatment, concludes a study in the Hastings Center Report.
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE.
Maternal exposure to nanoparticles of titanium dioxide (TiO2) affects the expression of genes related to the central nervous system in developing mice. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology found that mice whose mothers were injected with the nanoparticles while pregnant showed alteration in gene expression related to neurological dysfunction.
A new University of Illinois study suggests that moderate amounts of exercise alone can reduce the inflammation in visceral fat - belly fat, if you will - that has been linked with metabolic syndrome, a group of risk factors that predict heart disease and Type 2 diabetes.
Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter today from Zydus Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of Shire's 1.2g mesalamine delayed release tablets, LIALDA(R).
› Verified 6 days ago
| Provider Name | University Medical Associates Of The Medical University Of South Carol |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043241110 PECOS PAC ID: 6305758574 Enrollment ID: O20031105000291 |
News Archive
People with anorexia nervosa struggle with questions about their real, or "authentic," self - whether their illness is separate from or integral to them - and this conflict has implications for compulsory treatment, concludes a study in the Hastings Center Report.
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE.
Maternal exposure to nanoparticles of titanium dioxide (TiO2) affects the expression of genes related to the central nervous system in developing mice. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology found that mice whose mothers were injected with the nanoparticles while pregnant showed alteration in gene expression related to neurological dysfunction.
A new University of Illinois study suggests that moderate amounts of exercise alone can reduce the inflammation in visceral fat - belly fat, if you will - that has been linked with metabolic syndrome, a group of risk factors that predict heart disease and Type 2 diabetes.
Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter today from Zydus Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of Shire's 1.2g mesalamine delayed release tablets, LIALDA(R).
› Verified 6 days ago
| Provider Name | Coastal Podiatry Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1588965586 PECOS PAC ID: 7214110865 Enrollment ID: O20110321000260 |
News Archive
People with anorexia nervosa struggle with questions about their real, or "authentic," self - whether their illness is separate from or integral to them - and this conflict has implications for compulsory treatment, concludes a study in the Hastings Center Report.
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE.
Maternal exposure to nanoparticles of titanium dioxide (TiO2) affects the expression of genes related to the central nervous system in developing mice. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology found that mice whose mothers were injected with the nanoparticles while pregnant showed alteration in gene expression related to neurological dysfunction.
A new University of Illinois study suggests that moderate amounts of exercise alone can reduce the inflammation in visceral fat - belly fat, if you will - that has been linked with metabolic syndrome, a group of risk factors that predict heart disease and Type 2 diabetes.
Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter today from Zydus Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of Shire's 1.2g mesalamine delayed release tablets, LIALDA(R).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rahn Antonio Ravenell, DPM Po Box 751461, Charlotte, NC 28275-1461 Ph: (843) 792-6200 | Rahn Antonio Ravenell, DPM 171 Ashley Ave, Charleston, SC 29425-1810 Ph: (843) 792-1414 |
News Archive
People with anorexia nervosa struggle with questions about their real, or "authentic," self - whether their illness is separate from or integral to them - and this conflict has implications for compulsory treatment, concludes a study in the Hastings Center Report.
Dexcom, Inc., a leader in continuous glucose monitoring (CGM) for patients with diabetes, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM remote mobile communications device: Dexcom SHARE.
Maternal exposure to nanoparticles of titanium dioxide (TiO2) affects the expression of genes related to the central nervous system in developing mice. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology found that mice whose mothers were injected with the nanoparticles while pregnant showed alteration in gene expression related to neurological dysfunction.
A new University of Illinois study suggests that moderate amounts of exercise alone can reduce the inflammation in visceral fat - belly fat, if you will - that has been linked with metabolic syndrome, a group of risk factors that predict heart disease and Type 2 diabetes.
Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter today from Zydus Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application ("ANDA") for a generic version of Shire's 1.2g mesalamine delayed release tablets, LIALDA(R).
› Verified 6 days ago
Dr. Brandon Bultsma, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1565 Sam Rittenberg Blvd Ste 104, Charleston, SC 29407 Phone: 854-444-3129 | |
Marshall N. Kalinsky Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 325 Folly Rd, Ste 101, Charleston, SC 29412 Phone: 843-766-1632 Fax: 843-763-9430 | |
Dr. Brian G Ralph, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2270 Ashley Crossing Dr Ste 110, Charleston, SC 29414 Phone: 843-853-3474 Fax: 843-853-3500 | |
Dennis Emerson Martin, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9279 Medical Plaza Dr, Suite D, Charleston, SC 29406 Phone: 843-553-2223 Fax: 843-553-2275 | |
Dr. Matthew Fernandez, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1012 Physicians Dr, Charleston, SC 29414 Phone: 843-571-0602 | |
Musc Physicians Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Advanced Care Foot And Ankle Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 930 Folly Rd Ste D, Charleston, SC 29412 Phone: 843-606-0019 Fax: 843-604-0566 |